W3J-25233-69311
3 vaccinations
3 coded responses
31 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 626 / IL
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-29
Dose 1 — Moderna
- 2020-12-29
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-04
- 2021-01-05
- 2021-01-12
- 2021-01-20
-
2021-01-26
Dose 2 — Moderna
- 2021-01-26
-
2021-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-04-27
- 2021-07-27
-
2021-12-01
Dose 3 — Moderna
-
2021-12-04
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Headache, Vomiting, Abdominal pain · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationAdult check-in
-
2021-12-04
Report sent to call center — days 1–6 daily, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-12-06
Survey response — days 1–6 daily, dose 3MedDRA: Sinus congestion — Feeling: Fair · Fatigue or tirednessFree text: Sinus congestionMedDRA releases: 2024-11 · check-in free text available
- 2021-12-07
-
2021-12-08
Call successfulParticipant prefers to complete VAERS report online
- 2021-12-10
-
2021-12-17
Survey response — day 14, dose 3MedDRA: Migraine — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: MigrainesMedDRA releases: 2024-11 · check-in free text available
-
2021-12-17
Report sent to call center — day 14, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2021-12-20
- 2021-12-23
-
2021-12-29
Survey response — day 28, dose 3MedDRA: Migraine — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Ongoing migrainesMedDRA releases: 2024-11 · check-in free text available
- 2022-01-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Moderna | |
| 2 | 2021-01-26 | Moderna | |
| 3 | 2021-12-01 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-12-04 | Successful 2021-12-08 |
Participant prefers to complete VAERS report online |
| 2021-12-17 | Unsuccessful |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Sinus congestion
Release 10 — day 14, dose 3
Symptoms: Migraines
Release 10 — day 28, dose 3
Symptoms: Ongoing migraines
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Migraine | · | · | ✓ |
| SRO | Sinus congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release